Novedades en inmunoterapia: tumores genitourinarios, diabetes tipo 1, artritis reumatoidea

– Immunotherapy in the Treatment of Localized Genitourinary Cancers. JAMA Oncol, 2023. doi:10.1001/jamaoncol.2023.2174.
– Epitope-based precision immunotherapy of Type 1 diabetes. Hum Vaccin Immunother. 2023;19(1):2154098.
– Ozoralizumab: first Nanobody® therapeutic for rheumatoid arthritis. Expert Opinion on Biological Therapy, 2023;23(7).